Severe treatment‐resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab.

Severe treatment-resistant acute and recurrent vesicular chronic hand eczema successfully treated with dupilumab Keywords: case report; dupilumab; endogenous eczema; hand eczema; pompholyx EN case report dupilumab endogenous eczema hand eczema pompholyx 37 38 2 06/19/20 20200701 NES 200701 Chronic hand eczema (CHE) is an umbrella term that covers different subtypes. Anecdotal CHE patients with no history of atopic disease and with no exogenous exposures that can harm the skin barrier may suddenly develop severe acute and recurrent vesicular hand eczema, previously referred to as "pompholyx.". [Extracted from the article]